Literature DB >> 2920994

Hepatic metabolism of colloidal gold-low-density lipoprotein complexes in the rat: evidence for bulk excretion of lysosomal contents into bile.

G Renaud1, R L Hamilton, R J Havel.   

Abstract

Rats were treated with 17 alpha-ethinyl estradiol to induce high levels of low-density lipoprotein receptors in hepatocytes. When these rats were given intravenous injections of low-density lipoprotein-colloidal gold complexes, most of the gold (labeled with 195Au) appeared to be taken up by Kupffer cells, as were complexes of colloidal gold with albumin or polyvinylpyrrolidone. However, when these rats were also administered gadolinium chloride, which blocks Kupffer cell activity, most of the low-density lipoprotein-gold (but not gold complexed with albumin or polyvinylpyrrolidone) was taken up into hepatocytes by receptor-mediated endocytosis and concentrated in peribiliary lysosomes, as determined by electron microscopy. Colloidal gold taken up as a complex with low-density lipoprotein was excreted into the feces via the common bile duct at a maximal rate of about 5% daily, 4 to 12 days after injection. Thereafter, the rate of gold excretion fell off until reaching a plateau after 3 weeks. At this late time, most of the colloidal gold was shown by electron microscopy to be in Kupffer cells, whereas earlier (6 days after injection) it was contained mainly in older hepatocytic lysosomes, identified by lipofuscin granules. It is concluded that, in rats, hepatocytic lysosomes empty most of their contents into bile every week or two, apparently by exocytosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2920994     DOI: 10.1002/hep.1840090307

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  17 in total

1.  Rab5 is necessary for the biogenesis of the endolysosomal system in vivo.

Authors:  Anja Zeigerer; Jerome Gilleron; Roman L Bogorad; Giovanni Marsico; Hidenori Nonaka; Sarah Seifert; Hila Epstein-Barash; Satya Kuchimanchi; Chang Geng Peng; Vera M Ruda; Perla Del Conte-Zerial; Jan G Hengstler; Yannis Kalaidzidis; Victor Koteliansky; Marino Zerial
Journal:  Nature       Date:  2012-05-23       Impact factor: 49.962

2.  Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine.

Authors:  Steven K Libutti; Giulio F Paciotti; Adriana A Byrnes; H Richard Alexander; William E Gannon; Melissa Walker; Geoffrey D Seidel; Nargiza Yuldasheva; Lawrence Tamarkin
Journal:  Clin Cancer Res       Date:  2010-09-27       Impact factor: 12.531

3.  Effect of removing Kupffer cells on nanoparticle tumor delivery.

Authors:  Anthony J Tavares; Wilson Poon; Yi-Nan Zhang; Qin Dai; Rickvinder Besla; Ding Ding; Ben Ouyang; Angela Li; Juan Chen; Gang Zheng; Clinton Robbins; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

4.  Biodegradable Gold Nanoclusters with Improved Excretion Due to pH-Triggered Hydrophobic-to-Hydrophilic Transition.

Authors:  Elizabeth M Higbee-Dempsey; Ahmad Amirshaghaghi; Matthew J Case; Mathilde Bouché; Johoon Kim; David P Cormode; Andrew Tsourkas
Journal:  J Am Chem Soc       Date:  2020-04-21       Impact factor: 15.419

5.  Identification and distribution of proteins in isolated endosomal fractions of rat liver: involvement in endocytosis, recycling and transcytosis.

Authors:  A Pol; D Ortega; C Enrich
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

6.  Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.

Authors:  Stephanie Hirn; Manuela Semmler-Behnke; Carsten Schleh; Alexander Wenk; Jens Lipka; Martin Schäffler; Shinji Takenaka; Winfried Möller; Günter Schmid; Ulrich Simon; Wolfgang G Kreyling
Journal:  Eur J Pharm Biopharm       Date:  2010-12-31       Impact factor: 5.571

7.  Plasma cholesterol transport in anhepatic rats.

Authors:  S H Quarfordt; B Landis; G Cucchiaro; Y Yamaguchi; B Oswald
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

8.  In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Authors:  Rajiv Kumar; Indrajit Roy; Tymish Y Ohulchanskky; Lisa A Vathy; Earl J Bergey; Munawwar Sajjad; Paras N Prasad
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

9.  Technetium-99m labelled LDL as a tracer for quantitative LDL scintigraphy. II. In vivo validation, LDL receptor-dependent and unspecific hepatic uptake and scintigraphic results.

Authors:  T Leitha; A Staudenherz; B Gmeiner; M Hermann; M Hüttinger; R Dudczak
Journal:  Eur J Nucl Med       Date:  1993-08

10.  Biodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model system.

Authors:  Raghav Goel; Neha Shah; Rachana Visaria; Giulio F Paciotti; John C Bischof
Journal:  Nanomedicine (Lond)       Date:  2009-06       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.